Theodorus van der Kwast Selected Research

Theodorus van der Kwast Research Topics

Disease

44	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2009
39	Neoplasms (Cancer) 01/2022 - 02/2008
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
4	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 01/2019
4	Genomic Instability 11/2021 - 12/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 04/2022 - 06/2014
3	Adenocarcinoma 01/2022 - 08/2012
2	Carcinoma (Carcinomatosis) 08/2020 - 10/2019
2	Hypoxia (Hypoxemia) 01/2019 - 12/2014
2	Disease Progression 01/2017 - 11/2010
1	Lymphatic Metastasis 01/2022
1	Urinary Incontinence 01/2022
1	Prostatic Intraepithelial Neoplasia 11/2021
1	Contracture 01/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2017
1	Carcinogenesis 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2011
1	Polyps 12/2011
1	Wilms Tumor (Wilm's Tumor) 11/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2008

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2009
9	Prostate-Specific Antigen (Semenogelase)IBA 12/2020 - 03/2009
6	NucleotidesIBA 11/2021 - 07/2015
5	AndrogensIBA 01/2019 - 07/2009
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2017
3	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2019
3	Hormones (Hormone)IBA 01/2020 - 01/2016
3	ChromatinIBA 10/2019 - 07/2013
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 10/2019 - 06/2013
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 06/2014 - 02/2008
2	EnzymesIBA 04/2014 - 06/2013
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2020
1	NectinsIBA 08/2020
1	B7-H1 AntigenIBA 08/2020
1	Oxygen (Dioxygen)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Circular RNAIBA 01/2019
1	ProteomeIBA 01/2019
1	Long Noncoding RNAIBA 01/2018
1	Prostaglandins AIBA 01/2018
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2018
1	GP 4 (GP4)IBA 07/2017
1	Kallikreins (Kallikrein)IBA 01/2017
1	N 563IBA 01/2017
1	Formaldehyde (Formol)FDA Link 10/2016
1	ParaffinIBA 10/2016
1	Biological ProductsIBA 01/2016
1	Intergenic DNA (Junk DNA)IBA 01/2016
1	SteroidsIBA 01/2016
1	Complement System Proteins (Complement)IBA 12/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2014
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 09/2013
1	ML 7IBA 09/2013
1	Protease NexinsIBA 11/2012
1	Protein SIBA 10/2012
1	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 05/2012
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 12/2011
1	VimentinIBA 12/2011
1	Keratins (Keratin)IBA 12/2011
1	Platelet-Derived Growth FactorIBA 11/2010
1	platelet-derived growth factor AIBA 11/2010
1	Minor Histocompatibility AntigensIBA 09/2008
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2008
1	Interferon-gamma (Interferon, gamma)IBA 09/2008
1	HA-1 antigenIBA 09/2008
1	Keratin-20 (Cytokeratin 20)IBA 02/2008

Therapy/Procedure

12	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 04/2014
12	Therapeutics 01/2022 - 10/2012
7	Radiotherapy 01/2022 - 09/2013
6	Castration 10/2021 - 10/2012
2	Image-Guided Radiotherapy 01/2019 - 12/2014
1	Cystectomy 04/2022
1	Cystotomy 01/2020
1	Contraindications 01/2020
1	Nephroureterectomy 10/2019
1	Neoadjuvant Therapy 01/2019
1	Precision Medicine 02/2015
1	Extracorporeal Shockwave Therapy 08/2012
1	Nephrectomy 12/2011
1	Stem Cell Transplantation 09/2008